According to Elite Pharmaceuticals latest financial reports the cash on hand of ELTP is $7.83M, an decrease of -8.24% to 2022. At the end of 2022 company had $8.54M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $7.83M | -8.24% |
2022 | $8.54M | 167.33% |
2021 | $3.19M | 182.11% |
2020 | $1.13M | -50.31% |
2019 | $2.28M | - |